Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazumi Fujimoto

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 8, 2006
[Pharmacological characteristics and clinical efficacy of bosentan]Kazumi Fujimoto, Satoru Ikenoya
Internal Medicine (Tokyo, Japan)|December 3, 2013
Acquired von Willebrand syndrome associated with Hashimoto's thyroiditis and subcutaneous mucosa-associated lymphoid tissue lymphomaTakatoshi Koyama, Kazumi Fujimoto, Midori Shima
Plos One|May 23, 2013
Activation of coagulation by lenalidomide-based regimens for the treatment of multiple myelomaYu Isozumi, Reina Arai, Kazumi Fujimoto, et al.
Regulatory Peptides|February 24, 2010
Release of salusin-beta from human monocytes/macrophagesKengo Sato, Kazumi Fujimoto, Takatoshi Koyama, et al.
Scientific Reports|July 15, 2021
GIP_HUMAN[22-51] is a new proatherogenic peptide identified by native plasma peptidomicsTsuguto Masaki, Yoshio Kodera, Michishige Terasaki, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 10, 2021
Circulating prorenin: its molecular forms and plasma concentrationsKazumi Fujimoto, Sayuki Kawamura, Satoru Bando, et al.
Endocrine Journal|May 31, 2019
Basal glucagon hypersecretion and response to oral glucose load in prediabetes and mild type 2 diabetesRaishi Ichikawa, Koji Takano, Kazumi Fujimoto, et al.
Journal of Diabetes Investigation|July 22, 2023
Robust increase in glucagon secretion after oral protein intake, but not after glucose or lipid intake in Japanese people without diabetesRaishi Ichikawa, Koji Takano, Kazumi Fujimoto, et al.
Current Protein & Peptide Science|August 24, 2013
Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseasesTakuya Watanabe, Kengo Sato, Fumiko Itoh, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 10, 2022
Plasma and serum prorenin concentrations in diabetes, hypertension, and renal diseaseSayuki Kawamura, Kazumi Fujimoto, Akinori Hayashi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 8, 2006
[Pharmacological characteristics and clinical efficacy of bosentan]Kazumi Fujimoto, Satoru Ikenoya
Internal Medicine (Tokyo, Japan)|December 3, 2013
Acquired von Willebrand syndrome associated with Hashimoto's thyroiditis and subcutaneous mucosa-associated lymphoid tissue lymphomaTakatoshi Koyama, Kazumi Fujimoto, Midori Shima
Plos One|May 23, 2013
Activation of coagulation by lenalidomide-based regimens for the treatment of multiple myelomaYu Isozumi, Reina Arai, Kazumi Fujimoto, et al.
Regulatory Peptides|February 24, 2010
Release of salusin-beta from human monocytes/macrophagesKengo Sato, Kazumi Fujimoto, Takatoshi Koyama, et al.
Scientific Reports|July 15, 2021
GIP_HUMAN[22-51] is a new proatherogenic peptide identified by native plasma peptidomicsTsuguto Masaki, Yoshio Kodera, Michishige Terasaki, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 10, 2021
Circulating prorenin: its molecular forms and plasma concentrationsKazumi Fujimoto, Sayuki Kawamura, Satoru Bando, et al.
Endocrine Journal|May 31, 2019
Basal glucagon hypersecretion and response to oral glucose load in prediabetes and mild type 2 diabetesRaishi Ichikawa, Koji Takano, Kazumi Fujimoto, et al.
Journal of Diabetes Investigation|July 22, 2023
Robust increase in glucagon secretion after oral protein intake, but not after glucose or lipid intake in Japanese people without diabetesRaishi Ichikawa, Koji Takano, Kazumi Fujimoto, et al.
Current Protein & Peptide Science|August 24, 2013
Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseasesTakuya Watanabe, Kengo Sato, Fumiko Itoh, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 10, 2022
Plasma and serum prorenin concentrations in diabetes, hypertension, and renal diseaseSayuki Kawamura, Kazumi Fujimoto, Akinori Hayashi, et al.
Pageof 2